Therefore, pharmacological and/or dietary strategies able to restore adiponectin expression and secretion by improving inflammation-associated adipocyte dysfunction might beneficially impact several obesity-related metabolic and cardiovascular complications. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.